Search results
Results from the WOW.Com Content Network
McKesson (MCK), a health care services and information technology company, announced it agreed to purchase privately held US Oncology, a cancer treatment and research company, for approximately $2 ...
In 2010, McKesson acquired the oncology and physician services company US Oncology, Inc. for $2.16 billion, which was integrated into the McKesson Specialty Health business. [21] In April 2012, McKesson agreed to pay the United States $190M to settle allegations that it had inflated prices and overbilled Medicaid. [22]
McKesson would acquire about a 70% stake in the unit, which would be part of its U.S. pharmaceutical segment. Upon the close of the transaction, Florida Cancer Specialists — which operates in ...
In 2000 Broussard began working for US Oncology, which was acquired by the McKesson Corporation in 2010. [12] For six years, he was the company's chief financial officer. [13] He became president in 2005 [13] and was head of investor relations.
This page was last edited on 25 February 2018, at 07:43 (UTC).; Text is available under the Creative Commons Attribution-ShareAlike 4.0 License; additional terms may apply.
US Oncology Research, The US Oncology Network and McKesson Specialty Health Affiliated Investigators Participate in 90 Studies Featured at ASCO 2013 Studies have a wide-range of focus including ...
McKesson (MCK) is well positioned to outperform the market, ... Call us! 800-290-4726. Login / Join. Mail. Downloads; AOL App; Premium Subscriptions; PC Security; Reduce Junk Mail; Travel Tips;
On October 1, 2018, Amerisourcebergen agreed to pay $625M to resolve allegations that it had illegally repackaged and distributed oncology-supportive injectable drugs. [ 35 ] In October 2018, AmerisourceBergen agreed to pay $625 million to settle civil fraud allegations resulting from its repackaging and sale of adulterated drugs and unapproved ...